@8sarveshg - your posts are quite impactful to relate - way real life. Would you be able to help on momentum investing methods and ways to identify trends - these coupled with stop loss and quality orgs may help lots of starters to get a good jump start and preserve capital.
For e.g Syngene was on my watchlist for long ( Biocon has been in my core PF hence familiarwith group) and March gave opportunity to enter, what is not clear is that would you call Syngene a Momentum candidate( Pharma/CRAMS, Spl chem, native digital etc) in wake of Corona as prior to march fall it was still in high 30+PE most of times, and if that is the case of further tailwind and slight up rerating due to corona - what should be the signs one should look at balance momentum holdings as we go forward few qtrs - as to exit/reduce. Assume they would be external triggers ( outside company performance considering similar growth as past) e.g. when money rotates back to other sectors when economy revival signs appear? Apparently some 40L syngene shares have been bought by MFs in March and April- sizable for a low float , large promoter holding script.
Will you also categorize Biocon as whole as momentum story in current context as well( miss on Qtrly performance but mkt has held prices steady and high end on PE.
Thanks!